Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020097054 - TREATING NON-ALCOHOLIC STEATOHEPATITIS WITH CCK INHIBITORS

Publication Number WO/2020/097054
Publication Date 14.05.2020
International Application No. PCT/US2019/059833
International Filing Date 05.11.2019
IPC
A61K 31/221 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
22of acyclic acids, e.g. pravastatin
221with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
A61K 31/465 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
465Nicotine; Derivatives thereof
A61K 31/4748 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
47Quinolines; Isoquinolines
4748forming part of bridged ring systems
Applicants
  • GEORGETOWN UNIVERSITY [US]/[US]
Inventors
  • SMITH, Jill P.
Agents
  • MCKEON, Tina Williams
  • FERNANDEZ, Lizette M.
Priority Data
62/756,38406.11.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) TREATING NON-ALCOHOLIC STEATOHEPATITIS WITH CCK INHIBITORS
(FR) TRAITEMENT DE LA STÉATOHÉPATITE NON ALCOOLIQUE AVEC DES INHIBITEURS DE LA CCK
Abstract
(EN)
Provided herein are methods for treating nonalcoholic steatohepatitis (NASH) in a subject, comprising administering to a subject having NASH an effective amount of a CCK receptor inhibitor.
(FR)
L'invention concerne des méthodes de traitement de la stéatohépatite non alcoolique (SHNA) chez un sujet, consistant à administrer une quantité efficace d'un inhibiteur du récepteur de la CCK à un sujet ayant une SHNA.
Latest bibliographic data on file with the International Bureau